Lake Street Initiates Coverage On Alterity Therapeutics with Buy Rating, Announces Price Target of $10

Benzinga · 2d ago
Lake Street analyst Thomas Flaten initiates coverage on Alterity Therapeutics (NASDAQ:ATHE) with a Buy rating and announces Price Target of $10.